Abstract
Drug manufacturers that are signed up to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) will see their tax rates increase by more than 11 percentage points in 2023, the government has said. The new rate, confirmed on 15 December 2022, means that manufacturers will need to pay the government 26.5% of their […]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
